Clinical Trial Update: CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial comparing everolimus to calcineurin inhibitors for secondary prevention of skin cancers in heart transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• Calcineurin inhibitors
• Everolimus (everolimus)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cardiac Transplantation, Skin Cancer | Phase 3 | Status: COMPLETED